SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+6.36%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$312M
AUM Growth
+$312M
(+7.3%)
Cap. Flow
+$7.81M
Cap. Flow
% of AUM
2.5%
Top 10 Holdings %
Top 10 Hldgs %
56.55%
Holding
35
New
5
Increased
15
Reduced
12
Closed
2
Top Buys
| 1 |
Elevance Health
ELV
|
$5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$4.2M |
| 3 |
Amgen
AMGN
|
$4.05M |
| 4 |
Tandem Diabetes Care
TNDM
|
$3.46M |
| 5 |
Johnson & Johnson
JNJ
|
$3.32M |
Top Sells
| 1 |
Medtronic
MDT
|
$10.3M |
| 2 |
Gilead Sciences
GILD
|
$6.44M |
| 3 |
Pfizer
PFE
|
$5.83M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$5.66M |
| 5 |
Zimmer Biomet
ZBH
|
$2.73M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Rad Laboratories Class A
BIO
$8.06B
| $3.37M | 1.08% | 13,829 -3,000 | -18% | -$731K |
|
27
BioNTech
BNTX
$24B
| $2.73M | 0.88% | 30,000 -10,000 | -25% | -$911K |
|
28
Ascendis Pharma
ASND
$11.8B
| $2.65M | 0.85% | +17,000 | New | +$2.65M |
|
29
Biogen
BIIB
$19.4B
| $2.55M | 0.82% | 18,639 -10,361 | -36% | -$1.42M |
|
30
Lantheus
LNTH
$3.73B
| $2.44M | 0.78% | 25,000 -712 | -3% | -$69.5K |
|
31
Arcellx
ACLX
$3.85B
| $2.3M | 0.74% | +35,000 | New | +$2.3M |
|
32
Solventum
SOLV
$12.7B
| $2.28M | 0.73% | +30,000 | New | +$2.28M |
|
33
TG Therapeutics
TGTX
$4.65B
| $2.17M | 0.69% | +55,000 | New | +$2.17M |
|
34
Legend Biotech
LEGN
$6.41B
| – | – | -48,495 | Closed | -$1.58M |
|